I would like to ask you about...

Yes. Results from our activities can be considered to be relevant for a broad audience interested in health and science topics. Previous press releases we have been involved in include:
Yes. Please contact info@seerave.org to do so.
Not yet. But there is more and more evidence (Med diet) and FMT trials, that hint towards potential treatment and therapy routes in the future.
We unfortunately are not able to do so at this stage. However, we would refer you to:
  1. Personalised information on your cancer journey: My Cancer Navigator: https://www.anticancerfund.org/en/we-help-patients
  2. For globally ongoing clinical trials: clinicaltrials.gov
No, we will always follow a lead investor.
Usually seed funding rounds.
Seerave Foundation has a firm policy not to pay any overheads to governing institutions when making donations, gifts or grants to research partners. We therefore request applicants not to allocate any portion of the Seerave Foundation funds toward indirect costs or overheads but to direct the entire amount to the relevant research projects.
When we consider what to support, we look for new ideas and talented people aiming to further establish the evidence and translation around the nutrition - microbiome - metabolites - immune-system cancer axis, with a specific focus on melanoma, while we consider other cancer cases, that might help us to further establish the rationale for melanoma. Some specific criteria we have used to achieve our goals include:
  • We are looking out for a strong relation to our scientific axis
  • We support the entire value chain: from biomarker discovery, to translation into diagnostics and therapeutics and ultimately clinical implementation.
  • While we appreciate mechanistic work, we always aim for translation and patient impact, which guides our decision-making process for funding.
  • We aim for synergetic effects of our projects and always keep in mind future potential of pooling data or exchanging skills and knowledge.
  • Seerave encourages their projects to opt for open science principles including data sharing, transparency and accessibility of knowledge.
As strong believers in science, Seerave is in close contact with the academic teams and entrepreneurs. We consider ourselves as an active partner of the projects we support and apart from financial means, we like to contribute our own experience and network to accelerate impact.
Proposals are by invitation only.
Some of the project where we work with other philanthropic donors include:
  • PTFI
  • MDA project
  • The Microbiota Vault
Yes, we consider collaborations amongst philanthropic entities.
No. We support efforts that achieve our goals without regard to political affiliation.
The funding comes from a family endowment. David Rees co-founded the downstream oil company Greenergy, which was sold in May 2017 and the resulting proceeds were bequeathed to Seerave to fund its philanthropic activities.
Yes. We are a registered NPO under Non-Profit Organisations (Jersey) Law 2008, with registration number NPO-7095.
The Seerave Foundation was incorporated in Jersey on 26 March 2015 as a foundation under the Foundations (Jersey) Law, 2009, as amended, with registration number FD280. Our team on the ground can be based anywhere on the globe and is arranged virtually.
Seerave uses a combination of traditional grant donations towards academic researchers as well as equity investments into early-stage start-ups. Our project portfolio is built around international alliances of world-leading institutions, visionary scientists and entrepreneurs.
We are an active and innovative family foundation. We are inspired by personal experiences and driven by the conviction that through collaboration we will be able to accelerate science and catalyse innovation to enable personalised cancer treatment.